The treatment of depressive disorders in epilepsy: What all neurologists should know

Epilepsia

Volumn 54, Issue SUPPL. 1, 2013, Pages 3-12

  Kanner, Andres M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety disorder; Cognitive behavior therapy; Interictal dysphoric disorder; Major depressive episode; Selective serotonin reuptake inhibitors

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; ENZYME INDUCING AGENT; ETIRACETAM; GABAPENTIN; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VIGABATRIN; ZONISAMIDE;

ANXIETY; ANXIETY DISORDER; ARTICLE; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; EPILEPSY; FAMILY HISTORY; HIGH RISK PATIENT; HUMAN; MENTAL DISEASE; MOOD DISORDER; PANIC; PATIENT MONITORING; PATIENT REFERRAL; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; QUALITY OF LIFE; REMISSION; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; TREATMENT RESISTANT DEPRESSION;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; COGNITIVE THERAPY; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; EPILEPSY; HUMANS; SEROTONIN UPTAKE INHIBITORS;

EID: 84874744643     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12100     Document Type: Article

References (59)

1. Alper K, Schwartz KA, Kolts RL, Khan A,. (2007) Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 62: 345-354.
2. DSM-IV-TR. (2000) Diagnostic and statistical manual of mental disorders. 4th ed. American Psychiatric Press, Washington, DC.
3. Barry JJ, Ettinger AB, Friel P, Gilliam F, Harden CL, Hermann B, Kanner AM, Caplan R, Plioplys S, Salpekar J, Dunn D, Austin J, Jones J,. (2008) Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 13: S1-S29.
4. Blanchet P, Frommer GP,. (1986) Mood change preceding epileptic seizures. J Nerv Ment Dis 174: 471-476.
5. Blumer D, Zielinski J,. (1988) Pharmacologic treatment of psychiatric disorders associated with epilepsy. J Epilepsy 1: 135-150.
6. Brent DA, Crumrine PK, Varma RR, Allan M, Allman C,. (1987) Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics 80: 909-917.
7. Charney DS, Berman RM, Miller HL,. (1998) Treatment of depression. In, Schatzberg AF, Nemeroff CB, (Eds) Textbook of psychopharmacology. 2nd ed. American Psychiatric Association Press, Washington, DC, pp. 705-732.
8. Crail-Melendez D, Herrera-Melo A, Martínez-Juárez IE, Ramírez-Bermúdez J,. (2012) Cognitive-behavioral therapy for depression in patients with temporal lobe epilepsy: a pilot study. Epilepsy Behav 23: 52-56.
9. Davidson J,. (1989) Seizures and bupropion: a review. J Clin Psychiatry 50: 256-261.
10. Diem SJ, Blackwell TL, Stone KL, Yaffe K, Haney EM, Bliziotes MM, Ensrud KE,. (2007) Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 167: 1240-1245.
11. Favale E, Rubino V, Mainardi P, Lunardi G, Albano C,. (1995) The anticonvulsant effect of fluoxetine in humans. Neurology 45: 1926.
12. Favale E, Audenino D, Cocito L, Albano C,. (2003) The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure 12: 316-318.
13. Fawcett J, Scheftner WA, Fogg L,. (1990) Time-related predictors of suicide in major depression disorder. Am J Psychiatry 147: 1189-1194.
14. Gilliam FG, Black KJ, Carter J, Vahle V, Randall A, Sheline Y, Tsai W-Y, Lustman P,. (2009) Depression and health outcomes in epilepsy: a randomized trial. Presented at the 61st annual meeting of the American Academy of Neurology: 25 April-02 May 2009; Seattle, Washington, USA.
15. Goodwin R, Olfson M, Feder A,. (2001) Panic and suicidal ideation in primary care. Depress Anxiety 14: 244-246.
16. Hesdorffer DC, Hauser WA, Annegers JF,. (2000) Major depression is a risk factor for seizures in older adults. Ann Neurol 47: 246-249.
17. Hesdorffer DC, Hauser WA, Olafsson E, Ludvigsson P, Kjartansson O,. (2006) Depression and suicidal attempt as risk factor for incidental unprovoked seizures. Ann Neurol 59: 35-41.
18. Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA,. (2012) Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol 72: 184-191.
19. Hirschfield RMA, Bowden CL, Gitlin MJ,. (2002) Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 159 (Suppl. 4): 1-15.
20. Horne RL, Ferguson JM, Pope HG Jr, Hudson JI, Lineberry CG, Ascher J, Cato A,. (1988) Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry 49: 262-266.
21. Hovorka J, Herman E, Nemcová I,. (2000) Treatment of interictal depression with citalopram in patients with epilepsy. Epilepsy Behav 1: 444-447.
22. Jefferson JW, Pradko JF, Muir KT,. (2005) Bupropion for major depressive disorder: pharmacokinetic and formulation considerations. Clin Ther 27: 1685-1695.
23. Kanner AM, Kozak AM, Frey M,. (2000) The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav 1: 100-105.
24. Kanner AM, Soto A, Gross-Kanner H,. (2004) Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology 62: 708-713.
25. Kanner AM, Barry JJ, Gilliam F, Hermann B, Meador KJ,. (2010) Anxiety disorders sub-syndromic depressive episodes and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy? Epilepsia 51: 1152-1158.
26. Keller MB,. (2005) Untangling depression and anxiety: clinical challenges. J Clin Psychiatry 66: 1478-1487.
27. Kent JM, Gorman JM,. (1998) Venlafaxine. In, Schatzberg AF, Nemeroff CB, (Eds) Textbook of psychopharmacology. 2nd ed. American Psychiatric Association Press, Washington, DC, pp. 301-306.
28. Kerr MP, Mensah S, Besag F, de Toffol B, Ettinger A, Kanemoto K, Kanner A, Kemp S, Krishnamoorthy E, LaFrance WC Jr, Mula M, Schmitz B, van Elst LT, Trollor J, Wilson SJ,; International League of Epilepsy (ILAE) Commission on the Neuropsychiatric Aspects of Epilepsy. (2011) International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 52: 2133-2138.
29. Kessler RC, McGonagle KA, Zhao S,. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatrc disorders in the United States-results from the national comorbidity survey. Arch Gen Psychiatry 51: 8-19.
30. Kühn KU, Quednow BB, Thiel M, Falkai P, Maier W, Elger CE,. (2003) Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 4: 674-679.
31. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N,. (1998) Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351: 1303-1307.
32. Macrodimitris S, Wershler J, Hatfield M, Hamilton K, Backs-Dermott B, Mothersill K, Baxter C, Wiebe S,. (2011) Group cognitive-behavioral therapy for patients with epilepsy and comorbid depression and anxiety. Epilepsy Behav 20: 83-88.
33. Mamiya K, Kojima K, Yukawa E, Higuchi S, Ieiri I, Ninomiya H, Tashiro N,. (2001) Phenytoin intoxication induced by fluvoxamine. Ther Drug Monit 23: 75-77.
34. McLaughlin DP, McFarland K,. (2011) A randomized trial of a group based cognitive behavior therapy program for older adults with epilepsy: the impact on seizure frequency, depression and psychosocial well-being. J Behav Med 34: 201-207.
35. Mendez MF, Cummings J, Benson D,. (1986) Depression in epilepsy: significance and phenomenology. Arch Neurol 43: 766-770.
36. Mula M,. (2013) Treatment of anxiety disorders in epilepsy: An evidence-based approach. Eplilepsia 54 (Suppl. 1): 13-18.
37. Mula M, Sander JW,. (2007) Suicidal ideation in epilepsy and levetiracetam therapy. Epilepsy Behav 11: 130-132.
38. Mula M, Hesdorffer DC, Trimble M, Sander JW,. (2009) The role of titration schedule of topiramate for the development of depression in patients with epilepsy. Epilepsia 50: 1072-1076.
39. Mula M, Trimble MR, Yuen A, Liu RS, Sander JW,. (2003) Psychiatric adverse events during levetiracetam therapy. Neurology 61: 704-706.
40. Mula M, Jauch R, Cavanna A, Collimedaglia L, Barbagli D, Gaus V, Kretz R, Viana M, Tota G, Israel H, Reuter U, Martus P, Cantello R, Monaco F, Schmitz B,. (2008) Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy. Epilepsia 49: 650-656.
41. Nelson MH, Birnbaum AK, Remmel RP,. (2001) Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors. Epilepsy Res 44: 71-82.
42. Patsalos P, Perucca E,. (2003) Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2: 473-481.
43. Paykel ES, Ramana R, Cooper Z,. (1995) Residual symptoms after partial remission; an important outcome in depression. Psychol Med 25: 1171-1180.
44. Preskorn S, Fast G,. (1992) Tricyclic antidepressant induced seizures and plasma drug concentration. J Clin Psychol 53: 160-162.
45. Robertson M,. (1985) Depression in patients with epilepsy: an overview and clinical study. In, Trimble M, (ed) The psychoopharmacology of epilepsy. John Wiley and Sons Ltd, Chichester, U.K., pp. 65.
46. Rosenstein D, Nelson J, Jacobs S,. (1993) Seizures associated with antidepressants: a review. J Clin Psychol 54: 289-299.
47. Sackeim HA, Kupfer DJ, Luther J, Fava M, Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF,. (2006) Rosenbaum, acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163: 1905-1917.
48. Specchio LM, Iudice A, Specchio N, La Neve A, Spinelli A, Galli R, Rocchi R, Ulivelli M, de Tommaso M, Pizzanelli C, Murri L,. (2004) Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 27: 133-136.
49. Spina E, Perucca E,. (2002) Clinical significance of pharmacokinetic interactions between antiepileptic and psychtropic drugs. Epilepsia 43 (Suppl. 2): 37-44.
50. Stahl SM,. (2000) Depression and bipolar disorders. In, Stahl SM, (ed) Essential pharmacology: neuroscientific basis and practical applications. 2nd ed. Cambridge University Press, New York, pp. 135-197.
51. Tellez-Zenteno JF, Patten SB, Jetté N, Williams J, Wiebe S,. (2007) Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 48: 2336-2344.
52. Tollefson GD, Rosenbaum JF,. (1998) Selective serotonin reuptake inhibitors. In, Schatzberg AF, Nemeroff CB, (eds) Textbook of psychopharmacology. 2nd ed. American Psychiatric Association Press, Washington, DC, pp. 219-237.
53. Trimble MR,. (1998) Forced normalization and the role of anticonvulsants. In, Trimble MR, Schmitz B, (eds) Forced normalization and alternative psychoses of epilepsy. Wrightson Biomedical Publishing, Petersfield, pp. 169-178.
54. Trimble MR, Mula M,. (2005) Antiepileptic drug interactions in patients requiring psychiatric drug treatment. In, Majkowski J, Bourgeois B, Patsalos P, Mattson R, (eds) Antiepileptic drugs. Combination therapy and interactions. Cambridge University Press, Cambridge, U.K., pp. 350-368.
55. Trimble RM, RGreek small letter upsilon with dialytikasch N, Betts T, Crawford PM,. (2000) Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables. Seizure 9: 249-254.
56. van Praag HM, deKloet R, van Os J,. (2004) Diagnosing depression. In, van Praag HM, deKloet R, van Os J, (Eds) Stress, the brain and depression. Cambridge University Press, Cambridge, pp. 1-8.
57. Warden SJ, Robling AG, Sanders MS, Bliziotes MM, Turner CH,. (2005) Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 146: 685-693.
58. Young AS, Klap R, Shoal R, Wells KB,. (2008) Persistent depression and anxiety in the United States: prevalence and quality of care. Psychiatr Serv 59: 1391-1398.
59. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK,. (2006) A randomized trial of an N-methyl- d -aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63: 856-864.